Everest Pharma Launches Resiliva, First Global Generic of Resmetirom FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease FDA approves first MASH drug: Madrigal’s Rezdiffra breaks ground in notorious biopharma graveyard
